Skip to main content
Caplight Logo









Marginum

Marginum

Private
FinlandHealthcare & Life Scienceshttps://www.marginum.com/

Last Round

VC Round

Aug 22, 2025

Total Funding Raised

$1.82M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Marginum is a medical technology company that develops fluorescence-based tissue detection systems designed to help medical professionals treat cancer in patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

surgical guidancetumor resectionmedical devicefluorescence-guided surgerytissue detectionsurgical oncologyreal-time monitoringsurgical marginsmedtechsurgical navigationoperating room techsurgical hardwareintraoperative imaging

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Marginum Comparables

Compare Marginum with similar companies based on industry and business-model similarity.

Marginum comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beams
85%
OnLume Surgical
79%
Perimeter Medical Imaging AI Inc
78%

Marginum Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 22, 2025
SeedNov 10, 2023

Key People

Founding team and executive leadership

Juho Leskinen

CTO Co-Founder

Founding Team

Samu Lehtonen

CEO Co-Founder

Founding Team

Marginum Investors

Notable investors and investment history

Marginum investors
InvestorRounds
Nostetta VenturesVC Round, Seed
Lynx FinancialVC Round
Business FinlandVC Round, Seed
Redstone VCVC Round, Seed
AlmaralVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 143% MoM, reaching 2.2K.

  • Jun 24, 2026

    Monthly visitors grew 100% MoM.

Recent news

Latest coverage and updates

  • receives_awardAug 27, 2026

    Marginum Oy received award 2026 Export2X Internationalisation Award at Export2X Internationalisation Award on Aug 27th '26.

  • partners_withAug 11, 2026

    Marginum Oy partnered with ABS Med, Inc. on Aug 11th '26.

Marginum Filings

Explore SEC and related filing metadata, where available.

Marginum filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Marginum's valuation, stock price, and market status.

Is Marginum a public or private company?

Marginum is a private company.

What is the current stock price of Marginum?

Marginum is a private company with no public stock price. No recent secondary market data is available.

How much is Marginum worth (valuation)?

Valuation information for Marginum is not publicly available.

Can I buy Marginum stock?

Marginum shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Marginum's last funding round?

Marginum's most recent funding round was Early Funding on August 25, 2025.

Who are the main investors in Marginum?

Key investors in Marginum include Nostetta Ventures.

Will Marginum IPO soon?

No public IPO plans have been announced for Marginum.

How can I track Marginum secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Marginum's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFinland
Employee Range7
Year Founded2020
Last FundingAug 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?